Home › NDC Lookup › RxCUI directory › RxCUI 1656400

Belimumab 400 MG Injection — RxCUI 1656400

Name: Belimumab 400 MG Injection (RxCUI 1656400)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1656400 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1656400

Official nameBelimumab 400 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped3

Package NDCs mapped7

Reported Medicaid activity (SDUD)62,832 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Belimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Benlysta isn't a cure for lupus, but it helps control the disease. It targets an overactive part of your immune system that's driving inflammation and damage. It's used on top of y...
What exactly is Benlysta treating — is it a cure for lupus?
That depends on which form you're using. The intravenous (IV) version has to be given at a clinic or infusion center by a healthcare provider. The subcutaneous (under-the-skin) ver...
Can I give myself the shot at home, or do I have to go to a clinic every time?

📖 Read our full Belimumab Injection guide →

🕸️ Concept Web — How Belimumab 400 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Belimumab 400 MG Injection RxCUI 1656400 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Belimumab 1092437 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Benlysta 1092441 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Belimumab Injection 1656394 SCDF
- Belimumab Injectable Product 1159402 SCDG
- Belimumab Injection [Benlysta] 1656397 SBDF
- Benlysta Injectable Product 1171464 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Belimumab 400 MG 1656399 SCDC
- Belimumab 400 MG Injection [Benlysta] 1656402 SBD
- Belimumab 400 MG [Benlysta] 1656401 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Belimumab 400 MG SCDC · 1656399
Belimumab Injection SCDF · 1656394
Belimumab Injectable Product SCDG · 1159402

Brand-Name Concepts

Belimumab 400 MG Injection [Benlysta] SBD · 1656402
Belimumab 400 MG [Benlysta] SBDC · 1656401
Belimumab Injection [Benlysta] SBDF · 1656397
Benlysta Injectable Product SBDG · 1171464
Benlysta BN · 1092441

📦 FDA Products & Package NDCs

3 products · 7 package NDCs

7 package NDCs map to RxCUI 1656400 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
49401-0088-02	1 SYRINGE in 1 CARTON (49401-088-02) / 1 mL in 1 SYRINGE (4...	BENLYSTA	GlaxoSmithKline LLC	2017-07-20
49401-0088-35	4 SYRINGE in 1 CARTON (49401-088-35) / 1 mL in 1 SYRINGE (4...	BENLYSTA	GlaxoSmithKline LLC	2017-07-20
49401-0088-47	4 SYRINGE in 1 CARTON (49401-088-47) / 1 mL in 1 SYRINGE (4...	BENLYSTA	GlaxoSmithKline LLC	2017-07-20
49401-0088-50	1 SYRINGE in 1 CARTON (49401-088-50) / 1 mL in 1 SYRINGE (4...	BENLYSTA	GlaxoSmithKline LLC	2017-07-20
49401-0088-61	1 SYRINGE in 1 CARTON (49401-088-61) / 1 mL in 1 SYRINGE	BENLYSTA	GlaxoSmithKline LLC	2020-06-02
49401-0101-01	1 VIAL in 1 CARTON (49401-101-01) / 1.5 mL in 1 VIAL	BENLYSTA	GlaxoSmithKline LLC	2011-03-10
49401-0102-01	1 VIAL in 1 CARTON (49401-102-01) / 5 mL in 1 VIAL	BENLYSTA	GlaxoSmithKline LLC	2011-03-10

Observed labelers: GlaxoSmithKline LLC (7) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0490	Belimumab injection	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.